Table V.
Quantification of total (public and private) standardised demand for products containing recombinant activated clotting factor VII concentrate (expressed in milligrams per 1,000 population) in Italy and Italian regions, from 2007 to 2011.
Source: medicinal product traceability, processed and adapted by the Italian National Blood Centre.
Region | 2007 | 2008 | 2009 | 2010 | 2011 |
---|---|---|---|---|---|
Abruzzo | 0.3 | 0.6 | 0.9 | 0.1 | 0.6 |
Aosta Valley | 0.8 | 0.1 | 0.3 | 0.2 | 0.1 |
AP Bolzano | 0.4 | 0.1 | 0.1 | 0.2 | 0.1 |
AP Trento | 0.1 | 0.2 | 0.4 | 0.4 | 0.1 |
Apulia | 0.3 | 0.7 | 0.6 | 1.6 | 1.5 |
Basilicata | 0.1 | 0.5 | 0.0 | 0.5 | 0.3 |
Calabria | na | na | 1 | 1 | 1.7 |
Campania | 0.7 | 1.4 | 1.2 | 0.9 | 2 |
ER | 0.8 | 0.3 | 1.3 | 1.6 | 1.3 |
FVG | 5.7 | 5.7 | 4.6 | 6.9 | 8 |
Latium | 0.2 | 0.4 | 0.4 | 1.1 | 0.8 |
Liguria | 0.1 | 0.2 | 0.1 | 0.3 | 0.5 |
Lombardy | 0.7 | 0.7 | 0.3 | 0.7 | 0.7 |
Marche | 0.2 | 0.5 | 1.5 | 2.7 | 2.7 |
Molise | na | 0.1 | 0.1 | 0.3 | 0.2 |
Piedmont | 1.6 | 2 | 1.8 | 1.9 | 2.3 |
Sardinia | na | na | 1.5 | 0.3 | 0.0§ |
Sicily | na | na | 0.7 | 0.9 | 1 |
Tuscany | 0.2 | 3.1 | 3.9 | 2.4 | 3.4 |
Umbria | 0.3 | 0.2 | 0.5 | 0.3 | 0.7 |
Veneto | 0.6 | 0.9 | 1.1 | 1.3 | 1 |
Other* | 0.0 | 0.0 | na | na | 0.0 |
| |||||
Italy | 0.6 | 0.9 | 1.1 | 1.3 | 1.5 |
Legend AP: Autonomous Province; ER: Emilia-Romagna; FVG: Friuli-Venezia Giulia.
Values expressed with “0.0” do not identify absence of demand (which is expressed with “-”), but small quantities of consumption that should need too many decimal figures to be clearly inserted into the table.
Other*: movements of medicinal products not univocally defined. na: not assessable.